| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8211287 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 25 Pages |
Abstract
This study informs outcomes and expectations with IMRT-based reirradiation. The RPA classification identifies 3 distinct subgroups, which can guide patient selection for therapy and clinical trial design. RPA class III patients are not ideal candidates for protracted chemoradiation regardless of resection status.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Matthew C. MD, Nadeem MD, MS, Jimmy J. MD, PhD, Neal E. MD, Derek MD, PhD, Sara J. MD, Joshua MD, Musaddiq J. MD, John A. MD, Dwight E. MD, MBA, FACRO, FACR, Kristin A. MD, Jonathan J. MD, MBA, FACR, FASTRO, Samuel MD, Drexell H. MD, Comron BS,